Focus Stocks
Trading the Setup In Philip Morris
Published on Wednesday, 13 June 2012 05:32 Written by TradersHuddle Wire
New York, June 13th (TradersHuddle.com) - Philip Morris International Inc. (NYSE:PM) ended the trading session at $85.01, near its 50 day moving average set at $86.47. Philip Morris' price action placed the stock below this important level, which makes it difficult to be bought, as the stock will certainly face resistance as it approaches its 50 day moving average.
Philip Morris International Inc. (NYSE:PM) licensees, produces, and markets a wide range of branded cigarettes and tobacco products in markets outside of the United States of America. The portfolio include Marlboro, Merit, Parliament, and Virginia Slims.
The latest price action range, defined by a peaks and troughs algorithm, placed calculated support at $81.10 and resistance at $91.05. These levels will be closely monitored, as they provide great insight into the latest price dynamics.
If traders want to establish a position in Philip Morris, given the resistance expected as the stock approaches its 50 day moving average, a trade might materialize as the stock manages to break this important technical level. After the breakout, the 50 day moving average could be used as support going forward. However, until the break materializes, buying the stock is basically a gamble with 50-50 chance.
Related Articles
- Trading Idea: Key levels for Philip Morris
- Entry points for Philip Morris
- Philip Morris near Support
- Philip Morris Is Close to Resistance
- Trading Idea: Key levels for Philip Morris
- Philip Morris Is Close to Important Technical Levels
- Trading Idea: Entry Levels for Philip Morris
- Buying the Dip on Philip Morris?
- Trading Idea: Is Philip Morris close to Support?
- Trading Idea: Is Philip Morris Breaking Out?
Related Partner Headlines
- Philip Morris International Inc. Stock Buy Recommendation Reiterated (PM) - TheStreet.com
- Philip Morris International Inc. (PM): Today's Featured Tobacco Laggard - TheStreet.com
- Philip Morris International Inc. Stock Buy Recommendation Reiterated (PM) - TheStreet.com
- Philip Morris International Inc. (PM): Today's Featured Tobacco Laggard - TheStreet.com
- Philip Morris International Inc. Stock Buy Recommendation Reiterated (PM) - TheStreet.com
- Making the Most of Philip Morris - TheStreet.com
- Philip Morris International Inc. (PM): Today's Featured Tobacco Laggard - TheStreet.com
- Philip Morris International's Third Quarter Earnings Report - Investopedia
- Philip Morris International Third Quarter Earnings Preview - Investopedia
- Philip Morris International Inc. Stock Buy Recommendation Reiterated (PM) - TheStreet.com
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,387.58 Trade time:4:36PM EDT Value change:▲52.30 (0.34%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,669.16 Trade time:4:36PM EDT Value change:▲2.87 (0.17%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,502.12 Trade time:5:15PM EDT Value change:0.00 (0.00%)In The Wires
-
WD® to Demonstrate Solid State Hybrid Drive and 5 mm Technologies in Tablet, Thin and Light Devices at COMPUTEX TAIPEI 2013 -
Landstar To Participate In Keybanc Capital Markets Industrial, Automotive & Transportation Conference -
Elsevier Welcomes Dr. Tommaso Falcone as New Editor-in-Chief of the Journal of Minimally Invasive Gynecology -
Syneron Reports First Quarter 2013 Results -
Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye -
Alpha Natural Resources Completes Changes to Credit Facility -
iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza -
iTalk Launches 4G Hotspot at Las Vegas CTIA








